Last reviewed · How we verify

NCT03834311

The Effectiveness of Upper Extremity Isokinetic Strengthening in Post-stroke Hemiplegia

Completed NA Last updated 27 January 2020
What this trial tests

NA trial testing isokinetic strengthening in Stroke Rehabilitation in 24 participants. Completed in 15 November 2019.

Timeline
21 February 2019
Primary endpoint
15 November 2019
15 November 2019

Quick facts

Lead sponsorCukurova University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment24
Start date21 February 2019
Primary completion15 November 2019
Estimated completion15 November 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Cukurova University

Who can join

Adults 18 to 80, any sex, with Stroke Rehabilitation or Hemiplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomised controlled study will investigate the effectiveness of isokinetic strengthening on the upper extremity functionality and strength in post-stroke hemiplegic patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Effects of Upper Extremity Isokinetic Strengthening in Post-Stroke Hemiplegia: A Randomized Controlled Trial.
    Kerimov K, Coskun Benlidayi I, Ozdemir C, Gunasti O. · · 2021 · cited 13× · PMID 33765633 · DOI 10.1016/j.jstrokecerebrovasdis.2021.105729

Verify or expand the search:

Other recruiting trials for Stroke Rehabilitation

Currently open trials in the same condition.

Other Cukurova University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03834311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing